What comes out, must go back in: Court sides with FDA on “same surgical procedure” and “homologous use” definitions governing human cell and tissue products
FDA and DoD strengthen collaboration for medical products with military applications that could also be expanded to the general population
FDA aims to foster gene therapy developments with six new draft guidance documents
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
The Crackdown Continues: FDA Takes Action Against Company And Its Autologous Stem Cell Product, Alleging Significant Safety Concerns
New Legislation Increases Access to Medical Products for Military Applications
FDA Clarifies and Expands Eligibility for RMAT Designation for Gene Therapies
Firm/Org